Did you know?

Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival ...0.51. (4.29%) After Hours. About. Feed. News. Sentiment. Earnings. Fundamentals. Verastem Oncology Reports First Quarter 2024 Financial Results and Highlights Recent …Earnings Per Share - Diluted of $2.29; Earnings Per Share - Diluted, as Adjusted, of $6.86Total Sales of $7.9B; Net Flows of ($4.8B); Assets Under... HARTFORD, Conn., July 29, 2022...Total Valuation. Verastem has a market cap or net worth of $305.43 million. The enterprise value is $237.35 million. Market Cap. 305.43M. Enterprise Value. 237.35M.

Verastem Stock Forecast. All Analysts Top Analysts Stock Price Forecast. The 7 analysts with 12-month price forecasts for Verastem stock have an average target of 28.79, with a low estimate of 17.5 and a high estimate of 36. The average target predicts an increase of 598.79% from the current stock price of 4.12. Analyst Consensus: Strong Buy. Target …Reparto Universitario Reparto Universitario is a village in Santiago De Los Caballeros (Zona Urbana), Santiago de los Caballeros, Santiago Province.Reparto Universitario is situated close to the neighborhoods La Zurza and La Loteria.VSTM Stock 12 Months Forecast. $31.67. (187.91% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Verastem in the last 3 months. The average price target is $31.67 with a high forecast of $36.00 and a low forecast of $27.00. The average price target represents a 187.91% change from the last price of $11.00.Web-based application Pixolu helps you find images by their similarity to each other. Enter a search term and Pixolu searches the image indexes of Google, Yahoo, and Flickr. Once P...

Track ZyVersa Therapeutics Inc (ZVSA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors4.00%. BEAT. Home. Symbol. VSTM. Earnings. Checkout Verastem Inc (VSTM) earnings results, EPS expectations and actual EPS values for both quarterly and annual periods. Discover whether VSTM beat the street expectations or not? ….

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Verastem stocktwits. Possible cause: Not clear verastem stocktwits.

Verastem will have exclusive rights to obtain a license for each compound after pre-determined milestones in phase 1 studies are met. This biotech is going to end up having development and ...May 25, 2023 · Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed ...

Verastem, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing drugs to improve outcomes for patients with cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. Its lead FAK inhibitor is defactinib...10.86. +3.43%. Discover historical prices for VSTM stock on Yahoo Finance. View daily, weekly or monthly format back to when Verastem, Inc. stock was issued.

price of ozempic in mexico Track Aquestive Therapeutics Inc (AQST) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem Oncology is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia. Headquarters: Massachusetts. Founded: 2010. CEO: Brian Stuglik (Jul 2019–) wjbf news 6 augustapassword preceder crossword Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.STOCKTWITS CHART ART: MAY 24, 2024The Stocktwits Summary 📝. It was a quiet day to close off a quiet week in the U.S. stock market, with the S&P 500 posting … walmart hair salon caro mi Latest VERASTEM (VSTM) stock news, Verastem, Inc., operating as Verastem Oncology, is a biopharmaceutical company focusing on developin... Close. Discover the power of a Real-Time Financial News Database! ... Import your watchlist from Stocktwits and get a realtime overview of all news articles published regarding your favorite symbols. talladega infield mapcomenity net sephora visagone fishing memorial tattoos Verastem Oncology is currently conducting clinical trials with its RAF/MEK clamp avutometinib in RAS pathway-driven tumors as part of its Raf And Mek Program (RAMP). RAMP 301 is a Phase 3 ...Verastem will retain all rights to duvelisib outside of Japan.” The company has indicated another ex-US partnership by the end of 2018 as seen below. ... The skilled StockTwits user and VSTM ... weather underground pollock pines Verastem's (VSTM) avutometinib/Lumakras combination therapy gets the FDA's Fast Track designation to treat KRAS G12C-mutant metastatic NSCLC patients. The stock gains 8% in response. 366 grant blvd syracuse 13206border view elk ranchthe dump careers (3.81%) Today. Market Cap. $248.91M. Volume (M) 151,397.00. 52-Wk High. $15.18. 52-Wk Low. $4.26. ST Data. Watchers. New Watcher Rank. About. Feed. News. Sentiment. Earnings. Fundamentals. Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer.